Canntab Therapeutics: The First To Offer Medical Marijuana in Pill Form

- July 13th, 2018

Canntab Therapeutics (CSE:PILL) was featured on the CSE Blog highlighting the company’s one-of-a-kind marijuana pill delivery mechanism.

Canntab Therapeutics (CSE:PILL) has been featured on the CSE Blog highlighting the company’s one-of-a-kind marijuana pill delivery mechanism.

What gives Canntab an edge over its competitors is that it was founded by pharmaceutical industry professionals. In fact, company CEO Richard Goldstein talks about the danger of companies creating cannabis products without a pharmaceutical background. “A lot of it is being made in home kitchens and home basements. They’re not being made in the GMP environment. And yet, the marketplace continues to eat this stuff up. It’s quite scary at a level,” says Goldstein. The article also highlights Canntab’s merger with Telferscot Resources in April 2017.

Most importantly, according to the article, Canntab’s pill delivery mechanism is expected to go a long way in helping remove the stigma associated with marijuana by removing the smoking aspect.

To read the full article, click here.

Click here to connect with Canntab Therapeutics (CSE:PILL) for an Investor Presentation.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *